Azenta, Inc. (NASDAQ:AZTA) Holdings Reduced by Xponance Inc.

Xponance Inc. trimmed its holdings in Azenta, Inc. (NASDAQ:AZTA) by 3.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,368 shares of the company’s stock after selling 242 shares during the quarter. Xponance Inc.’s holdings in Azenta were worth $480,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. DAVENPORT & Co LLC increased its stake in shares of Azenta by 1.5% during the third quarter. DAVENPORT & Co LLC now owns 25,816 shares of the company’s stock valued at $1,296,000 after acquiring an additional 373 shares during the period. TFC Financial Management Inc. bought a new position in shares of Azenta during the 3rd quarter valued at about $25,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Azenta by 11.9% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,344 shares of the company’s stock valued at $670,000 after purchasing an additional 1,416 shares during the last quarter. Advisor Partners II LLC acquired a new position in Azenta in the third quarter worth approximately $208,000. Finally, Teacher Retirement System of Texas boosted its stake in shares of Azenta by 78.7% during the 3rd quarter. Teacher Retirement System of Texas now owns 1,147,753 shares of the company’s stock worth $57,606,000 after acquiring an additional 505,412 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Stock Up 1.3 %

Shares of NASDAQ:AZTA opened at $52.18 on Friday. The firm has a fifty day moving average of $59.62 and a two-hundred day moving average of $58.98. Azenta, Inc. has a 12-month low of $36.01 and a 12-month high of $69.16. The firm has a market capitalization of $2.91 billion, a P/E ratio of -168.32 and a beta of 1.53.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The business had revenue of $154.32 million during the quarter, compared to analyst estimates of $151.86 million. Equities research analysts expect that Azenta, Inc. will post 0.27 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on AZTA. Stephens reaffirmed an “equal weight” rating and set a $70.00 target price on shares of Azenta in a research report on Thursday, February 8th. Jefferies Financial Group initiated coverage on shares of Azenta in a research report on Thursday, April 4th. They issued a “hold” rating and a $64.00 target price on the stock. B. Riley upped their price target on shares of Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Evercore ISI lowered their price objective on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating on the stock in a research report on Thursday, April 4th. Finally, Needham & Company LLC restated a “buy” rating and issued a $75.00 target price on shares of Azenta in a report on Monday, April 8th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $69.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.